FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3084268512> ?p ?o ?g. }

• W3084268512 endingPage "2097" @default.
• W3084268512 startingPage "2089" @default.
• W3084268512 abstract "Hepatic veno-occlusive disease or sinusoidal obstruction syndrome (VOD/SOS) is a threatening complication after both autologous and allogeneic hematopoietic stem cell transplantation (HSCT), with high mortality rates despite early medical treatment, including the use of defibrotide (DF). We retrospectively analyzed 185 unmanipulated haploidentical (haplo-) HSCT with post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis performed consecutively between 2011 and June 2019 in a single center. Seventeen patients (9.2%) were diagnosed with VOD/SOS. Based on revised European Society for Blood and Marrow Transplantation severity criteria, the VOD/SOS cases were classified as mild in 2 patients (11.7%), moderate in 2 (11.7%), severe in 2 (11.7%), and very severe in 11 (64.9%). Thirteen patients (76%) were treated with DF, including all patients with severe or very severe VOD/SOS, except 1 patient with CNS hemorrhage. Sixteen patients (94%) were alive at day +100 after HSCT. Seven patients (41%) with very severe VOD/SOS were treated with transjugular intrahepatic portosystemic shunt (TIPS) owing to rapid clinical or analytical deterioration or refractory hepatorenal syndrome despite medical treatment, including DF. TIPS insertion was performed at a median time since VOD/SOS diagnosis of 4 days (range, 1 to 28 days) without technical complications in any case. The median hepatic venous pressure gradient before and after TIPS treatment was 24 mmHg (range, 14 to 29 mmHg) and 7 mmHg (range, 2 to 11 mmHg), respectively, with a median drop of 16 mmHg (range, 9 to 19 mmHg). Following TIPS insertion, all patients showed clinical improvement with hepatomegaly, ascites, and renal failure resolution, and all showed analytical improvement with reduced alanine aminotransferase (ALT), creatinine, and international normalized ratio values, except for patient 2, whose indication for TIPS was refractory hepatorenal syndrome with a normal ALT level. The 6 patients who had initiated DF before TIPS insertion completed 21 days of treatment. All patients met the criteria for complete remission (CR) at a median of 8 days after TIPS insertion (range, 2 to 82 days). The 100-day overall survival was 100%. For patients with rapid progressive VOD/SOS, early TIPS insertion allowed completion of DF therapy. The use of TIPS together with DF resulted in CR and no associated complications with no VOD/SOS-associated mortality despite high severity. In our experience, timely and individualized use of TIPS significantly improves outcomes of very severe VOD/SOS after haplo-HSCT. Therefore, TIPS should be promptly considered in rapidly progressive cases." @default.
• W3084268512 created "2020-09-14" @default.
• W3084268512 creator A5012705790 @default.
• W3084268512 creator A5022715975 @default.
• W3084268512 creator A5034185385 @default.
• W3084268512 creator A5034694882 @default.
• W3084268512 creator A5043896341 @default.
• W3084268512 creator A5043991937 @default.
• W3084268512 creator A5054200855 @default.
• W3084268512 creator A5055646240 @default.
• W3084268512 creator A5057322991 @default.
• W3084268512 creator A5061213865 @default.
• W3084268512 creator A5064816861 @default.
• W3084268512 creator A5067861051 @default.
• W3084268512 creator A5081117905 @default.
• W3084268512 date "2020-11-01" @default.
• W3084268512 modified "2023-10-18" @default.
• W3084268512 title "Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide" @default.
• W3084268512 cites W154432024 @default.
• W3084268512 cites W1779344217 @default.
• W3084268512 cites W1963834280 @default.
• W3084268512 cites W1966771497 @default.
• W3084268512 cites W1968872381 @default.
• W3084268512 cites W1970563122 @default.
• W3084268512 cites W1972172571 @default.
• W3084268512 cites W1973519172 @default.
• W3084268512 cites W1982216156 @default.
• W3084268512 cites W1989765997 @default.
• W3084268512 cites W1990889311 @default.
• W3084268512 cites W1993783426 @default.
• W3084268512 cites W199387403 @default.
• W3084268512 cites W2010732369 @default.
• W3084268512 cites W2011332149 @default.
• W3084268512 cites W2019841646 @default.
• W3084268512 cites W2022481190 @default.
• W3084268512 cites W2031221807 @default.
• W3084268512 cites W2032544348 @default.
• W3084268512 cites W2037010003 @default.
• W3084268512 cites W2039334806 @default.
• W3084268512 cites W2059353285 @default.
• W3084268512 cites W2064322221 @default.
• W3084268512 cites W2066886754 @default.
• W3084268512 cites W2067329870 @default.
• W3084268512 cites W2071225816 @default.
• W3084268512 cites W2074535545 @default.
• W3084268512 cites W2077086197 @default.
• W3084268512 cites W2079167213 @default.
• W3084268512 cites W2082582759 @default.
• W3084268512 cites W2083438952 @default.
• W3084268512 cites W2085623459 @default.
• W3084268512 cites W2085644837 @default.
• W3084268512 cites W2113444904 @default.
• W3084268512 cites W2166247867 @default.
• W3084268512 cites W2180061107 @default.
• W3084268512 cites W2242834385 @default.
• W3084268512 cites W2295805773 @default.
• W3084268512 cites W2315528361 @default.
• W3084268512 cites W2341503181 @default.
• W3084268512 cites W2346035223 @default.
• W3084268512 cites W2396687607 @default.
• W3084268512 cites W2462936585 @default.
• W3084268512 cites W2605460979 @default.
• W3084268512 cites W2608455444 @default.
• W3084268512 cites W2681369214 @default.
• W3084268512 cites W2730231599 @default.
• W3084268512 cites W2803440649 @default.
• W3084268512 cites W2805955160 @default.
• W3084268512 cites W2809534462 @default.
• W3084268512 cites W2917470334 @default.
• W3084268512 cites W2917965199 @default.
• W3084268512 cites W2942964452 @default.
• W3084268512 cites W2967174380 @default.
• W3084268512 cites W2986893246 @default.
• W3084268512 cites W3016355165 @default.
• W3084268512 cites W5387557 @default.
• W3084268512 cites W571628560 @default.
• W3084268512 doi "https://doi.org/10.1016/j.bbmt.2020.08.006" @default.
• W3084268512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32791193" @default.
• W3084268512 hasPublicationYear "2020" @default.
• W3084268512 type Work @default.
• W3084268512 sameAs 3084268512 @default.
• W3084268512 citedByCount "7" @default.
• W3084268512 countsByYear W30842685122021 @default.
• W3084268512 countsByYear W30842685122022 @default.
• W3084268512 countsByYear W30842685122023 @default.
• W3084268512 crossrefType "journal-article" @default.
• W3084268512 hasAuthorship W3084268512A5012705790 @default.
• W3084268512 hasAuthorship W3084268512A5022715975 @default.
• W3084268512 hasAuthorship W3084268512A5034185385 @default.
• W3084268512 hasAuthorship W3084268512A5034694882 @default.
• W3084268512 hasAuthorship W3084268512A5043896341 @default.
• W3084268512 hasAuthorship W3084268512A5043991937 @default.
• W3084268512 hasAuthorship W3084268512A5054200855 @default.
• W3084268512 hasAuthorship W3084268512A5055646240 @default.
• W3084268512 hasAuthorship W3084268512A5057322991 @default.
• W3084268512 hasAuthorship W3084268512A5061213865 @default.
• W3084268512 hasAuthorship W3084268512A5064816861 @default.
• W3084268512 hasAuthorship W3084268512A5067861051 @default.

• next